Cancer Center at Greater Baltimore Medical

Baltimore, Maryland 21153

0 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumors

Studies at this site

• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors — Completed